Material
Etafilcon A, shown in vitro to attract and retain lysozyme in its natural state, with no clinical study linking that lysozyme profile to a clinical benefit.
Wetting agent
Polyvinylpyrrolidone (PVP), part of Lacreon Technology, with no detectable amount released over a 24-hour simulated wear period.
Study
Subjective comfort was a primary or secondary endpoint in 14 studies posted on ClinicalTrials.gov comparing the 1-DAY ACUVUE MOIST brand family with competitors' products, and no hydrogel daily disposable competitor beat it, reviewed as of October 31, 2025.
